Article Versions Notes

Wang H, Li R, Rao Y, Liu S, Hu C, Zhang Y, Meng L, Wu Q, Ouyang Q, Liang H, et al. Enhancement of the Bioavailability and Anti-Inflammatory Activity of Glycyrrhetinic Acid via Novel Soluplus^®—A Glycyrrhetinic Acid Solid Dispersion. Pharmaceutics. 2022; 14(9):1797. https://doi.org/10.3390/pharmaceutics14091797

Wang, Hao, Runwei Li, Yuan Rao, Saixing Liu, Chunhui Hu, Yong Zhang, Linchao Meng, Qilin Wu, Qiuhong Ouyang, Hao Liang, and et al. 2022. "Enhancement of the Bioavailability and Anti-Inflammatory Activity of Glycyrrhetinic Acid via Novel Soluplus^®—A Glycyrrhetinic Acid Solid Dispersion" Pharmaceutics 14, no. 9: 1797. https://doi.org/10.3390/pharmaceutics14091797

Wang, H., Li, R., Rao, Y., Liu, S., Hu, C., Zhang, Y., Meng, L., Wu, Q., Ouyang, Q., Liang, H., & Qin, M. (2022). Enhancement of the Bioavailability and Anti-Inflammatory Activity of Glycyrrhetinic Acid via Novel Soluplus^®—A Glycyrrhetinic Acid Solid Dispersion. Pharmaceutics, 14(9), 1797. https://doi.org/10.3390/pharmaceutics14091797